Latest Stock Split Details
Key information about Inhibikase Therapeutics, Inc.'s most recent stock split
Split Date: 2023-06-30
Split Ratio: 1:6
Price Before Split: $0.60
Price After Split: $0.10
Developer API
Get IKT split history as JSON
Dates, ratios, split factors, and pre/post-split prices from a single REST call. Look up by ticker, CIK, CUSIP, or ISIN. Free tier, no scraping.
GETapi.roic.ai/v2/stock-splits/IKT
Impact of the Stock Split
Understanding what this means for shareholders
- The total value of your investment remains the same
- You now own 6.00 times fewer shares (a 1:6 ratio)
- The price per share is increased proportionally
Historical Stock Splits
A comprehensive history of Inhibikase Therapeutics, Inc.'s stock splits
| Date | Ratio | Is Reverse Split | Price Before Split | Price After Split |
|---|---|---|---|---|
| 2023-06-30 | 1:6 | Yes | $0.60 | $0.10 |
About Inhibikase Therapeutics, Inc.
Company overview and industry information
Inhibikase Therapeutics, Inc. (IKT) operates in the Medical - Pharmaceuticals industry. The recent 1-for-6 reverse stock split is part of the company's strategy to adjust its share price and potentially meet stock exchange listing requirements.
Medical - Pharmaceuticals
Go to Inhibikase Therapeutics, Inc. Summary